Ikarian Capital, LLC Chemo Centryx, Inc. Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
BUY
$9.59 - $50.88 $4.52 Million - $24 Million
471,339 Added 1273889.25%
471,376 $6.31 Million
Q3 2020

Nov 16, 2020
SELL
$46.35 - $61.69 $2.15 Million - $2.86 Million
-46,386 Reduced 99.92%
37 $1,000
Q4 2019

Jan 31, 2020
BUY
$6.81 - $39.55 $316,140 - $1.84 Million
46,423 New
46,423 $1.84 Million

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email